摘要
本文应用思密达减轻因静点乳糖酸红霉素(EM-L)而引起的不良反应。观察92例小儿患者,静点EM-L400余次,不良反应的发生率由78.95％下降为21.43％。(P<0.01)本文还对不良反应的原因和思密达的作用机理作了探讨并提出了预防措施。
By using Smecta to alleviate the side-effect caused during intravenous drip of ery-thromycin lactobionatein in a group was observed in this article. The observed 92 cases ofchildren were treated more than 400 times with EM-J by intravenous drip. After usingSmecta, the frequency of side-effect decreased from 78. 95% to 21. 43%. The causesof side-effect produced by administrating erythromycin lactobionate and the mechanismof all eviating it by introducing Smecta were discussed. The points of attention were alsoadvised.
出处
《大连大学学报》
1995年第3期392-395,共4页
Journal of Dalian University
关键词
乳糖酸红霉素
思密达
不良反应
静脉点滴
Erythromycin Lactobionate Smeta Side-Effect Intravenous Drip
